02269.HK
WuXi Biologics (Cayman) Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 49.18
−3.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 28.69x
- P/E 2027E
- 23.11x
- P/E 2028E
- 18.81x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 19.07x
- PEG TTM
- 0.87x
- Price / book
- 3.53x
- Price / sales
- 3.90x
- Price / cash flow
- 16.45x
Enterprise value
- Enterprise value
- HKD 193.6B
- EV / sales
- 3.81x
- EV / EBITDA
- 10.23x
- EV / EBIT
- 12.32x
- Market cap
- HKD 198.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026